Integral Diagnostics Limited (IDX.AX)
Operates medical imaging clinics providing X-rays, MRIs, and CT scans across Australia and New Zealand.
2.09+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-22.0%
The outlook
IDX.AX trades near its 52-week lows with strong analyst support—the consensus leans "Strong Buy" with an average price target around 48% above current levels. The stock sits mixed relative to its moving averages, suggesting near-term uncertainty despite the bullish analyst lean. The elevated trailing P/E of 52.3 reflects market expectations that may take time to materialize.
What’s behind the score
Analyst consensusStrong Buy — 1.5 avg of 13 analysts
Price trendMixed vs its moving averages
52-week range16% of the way from its 52-week low to high
Price targetAvg target +48% vs current price
Analyst price target
~12-month · 13 analysts3.10average target+48.3% vs now
Now 2.09
Low 2.15High 3.80
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$779.7M
52-wk high
3.07
52-wk low
1.91
50-day avg
2.05
200-day avg
2.34
Trailing P/E
52.3